Furthermore, the presence of JAK2 gene mutations was accompanied by higher IRF1 and NF-kB expression, while MPN patients with CALR gene mutations showed lower NF-kB and pJAK2 expression (Fig. 2J and Supplementary Fig. S4). This evidence concerns the gene JAK2 and myeloproliferative disorder.